Organisation: GlaxoSmithKline
FTC opposes 300 more Orange Book patents
The Federal Trade Commission is challenging an additional 300 drug product patents listed with the US drug regulator’s Orange Book, including Novo Nordisk’s blockbuster weight loss drug Ozempic.
01 May 2024
As old as you feel: The Briefing for 16 April 2024
Turning 10 years old today, the UK’s Competition and Markets Authority marked the occasion by boasting about its enforcement efforts. To date, the agency says it has launched over 1400 cases, projects and investigations and returned at least £15.6 billion in savings to consumers. Also in The Briefing, Meta complies with an interim injunction by shutting down its Threads social networking service and GSK pays a no-poach fine in Turkey.
16 April 2024
Turkcell and Ericsson subsidiary fined in Turkish no-poach probe
Turkey’s Competition Authority has fined the country’s leading mobile phone operator and seven other companies for colluding not to hire each other’s employees.
04 March 2024
GSK, AstraZeneca, Johnson & Johnson and others raided in Turkish labour market probe
Turkey’s Competition Authority has launched a sprawling investigation into 19 companies, including AstraZeneca, Johnson & Johnson, Pfizer, GlaxoSmithKline and Panasonic, for allegedly forming no-poach agreements in the pharmaceutical sector.
01 December 2023
South Africa discloses Johnson & Johnson probe following press scrutiny
An “unprecedented” probe by South Africa’s competition watchdog is investigating whether Johnson & Johnson charged excessive prices and unlawfully blocked rivals from selling generic versions of its tuberculosis drug.
15 September 2023
Yulchon snags former KFTC litigation and mergers director
Yoon Hwan Hwang, who served as the director of litigation and merger review at Korea’s Fair Trade Commission, has joined Yulchon as a partner in Seoul.
30 August 2023
Korea fines 32 vaccine companies for bid rigging
GlaxoSmithKline and 31 other companies in the vaccine sector are facing fines of €28.6 million from Korea’s Fair Trade Commission for rigging bids to supply the government’s National Immunisation Programme.
21 July 2023
Goodwin continues expansion with Linklaters hire in London
Eram Khan has left Linklaters to join Goodwin’s growing European antitrust partnership in London, becoming the firm’s second non-US antitrust partner.
04 January 2023
Spain hits Merck with €39 million abuse fine for sham litigation
Spain’s antitrust watchdog has fined Merck €38.9 million for abusing its dominant position in the market for a type of contraceptive, finding the company unlawfully delayed the entry of a competing product through deceptive patent litigation.
25 October 2022
KFTC fines AstraZeneca and Alvogen for anticompetitive agreement
Korea’s competition watchdog has fined AstraZeneca and fellow drugmaker Alvogen a combined €1.9 million for colluding to suppress generic competition to the former’s prostate and breast cancer drug.
14 October 2022